Mutational biosynthetic antiparasitic antibiotic structurally related to the avermectins, q.v. Isoln: S. P. Gibson et al., EP 214731; eidem, US 5089480 (1987, 1992 both to Pfizer). Mutational biosynthesis: C. J. Dutton et al., J. Antibiot. 44, 357 (1991). Pharmacokinetics and efficacy in cattle: Vet. Parasitol. 49, 1-119 (1993). Clinical evaluation as prophylactic in canine spirocercosis: E. Lavy et al., Res. Vet. Sci. 75, 217 (2003).